LEVOFLOXACIN TABLETS

The Defense Logistics Agency awarded a delivery order, SPE2DP-26-F-7586, to DMS PHARMACEUTICAL GROUP INC under the base contract SPE2DX-25-D-9900 for the procurement of six bottles of Levofloxacin Tablets, identified by NSN 6505014446632 and NDC codes 31722-0722-50 and 51407-0429-50. The total contract value is $1,759.44, with a firm-fixed-price structure and no variance allowance, meaning no adjustments for quantity changes are permitted. Delivery is required by July 29, 2026, to Joint Base Pearl Harbor, Hawaii, under FOB destination terms, with the contractor responsible for all costs and risks until receipt at the delivery point. The contractor, certified as a Small Disadvantaged Business and a Women-Owned Small Business, must comply with DLA and FDA standards, including proper labeling and traceability using NDC codes. Packaging and marking requirements mandate inclusion of the base contract number SPE2DX-25-D-9900 and the delivery order number SPE2DP-26-F-7586 on all shipping documentation, with no specific MIL-STD or preservation standards detailed. Invoicing must follow DFARS 252.232-7003, which mandates electronic submission through WAWF, and payment will be processed by the Defense Finance and Accounting Service at Columbus, Ohio, using appropriation identifier 97X4930 5CBX 001 2620 S33189. The Contracting Officer is Lisa Quinn, with Shairy M. Cartagena serving as the administrative contact; no Contracting Officer’s Representative or Technical Representative is designated. Inspection and acceptance will be conducted by the Government at the destination, and the award was issued without formal evaluation factors or special contract requirements beyond standard logistical and financial terms. The contract represents a single-line-item delivery order issued under an IDIQ framework with no options or future quantities specified.